Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Preclinical Development of AT1412, a Patient Derived CD9 Antibody That Does Not Induce Thrombosis for Treatment of B ALL

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-134088

Published: 2020

Journal Articles

Real-World Effectiveness and Safety of Blinatumomab in Adults with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukaemia in Europe: 3-Year Results in Philadelphia Chromosome-Negative Patients and a Subset of Patients with Late First Relapse

Xavier Thomas, MD PhD, Anita W Rijneveld, MD PhD, Nicola Fracchiolla, MD, Cyril Šálek, MD, Alexandros Spyridonidis, MD PhD, Sabina Chiaretti, MD PhD, Naufil Alam, PhD, Isabella Pezzani Grueter, PharmD, Abeera Mohammad, MSc, William Kormany, MD, Georg Kreuzbauer, MD, Alessandro Rambaldi, MD

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-134470

Published: 2020

Journal Articles

AT1412, a Patient-Derived Antibody in Development for the Treatment of CD9 Positive Precursor B-Acute Lymphoblastic Leukemia

Greta De Jong, Sophie E Levie, Remko Schotte, PhD, Wouter Pos, PhD, Daniel Go, Etsuko Yasuda, Madalina Cercel, Susan E van Hal-van Veen, Esmay Frankin, Anikó Szabó, MD, Julien Villaudy, PhD, Pauline M van Helden, PhD, Hans van Eenennaam, PhD, Hergen Spits, PhD, Anita W Rijneveld, MD PhD, Mette D Hazenberg, MD PhD

Blood (2019) 134 (Supplement_1): 4461.

https://doi.org/10.1182/blood-2019-127894

Published: 2019

Journal Articles

Extensive RAG-Mediated Rearrangements and Mutations in BCR-ABL1 and BCR - ABL1 -like Adult Acute Lymphoblastic Leukemia

Mathijs A. Sanders, PhD, Anikó Szabó, MD, Carla Exalto, Remco Hoogenboezem, Annelieke Zeilemaker, Jasper E. Koenders, Peter van Geel, Anita Schelen, H. Berna Beverloo, PhD, Jan J. Cornelissen, MD PhD, Anita W. Rijneveld, MD PhD, Peter J.M. Valk, PhD

Blood (2016) 128 (22): 4067.

https://doi.org/10.1182/blood.V128.22.4067.4067

Published: 2016

Journal Articles

N-Acetylcysteine in Patients with Sickle Cell Disease: A Randomized Controlled Trial

Blood (2016) 128 (22): 123.

https://doi.org/10.1182/blood.V128.22.123.123

Published: 2016

Journal Articles

Value-Based Health Care (VBHC) in Sickle Cell Disease: A Dutch Initiative

Fia ten Brink, MD, Anita W. Rijneveld, MD PhD, Marie-José J.A.G. Claessen, MD, Amando J. Heesterman, Thea J. van Zon, Sonja A.M.C. Teuben, Cora J.D. Onna Van - Walraven, Alice M.A. Goncalves Silva, Francis van Veelen, Renée du Mortier, Marieke A.M.S. Joosten, MD PhD, Fred Petrij, MD PhD, Jan A. Hazelzet, MD PhD, Marjon H. Cnossen, MD PhD

Blood (2015) 126 (23): 5572.

https://doi.org/10.1182/blood.V126.23.5572.5572

Published: 2015

Journal Articles

Extensive Molecular Analysis Strongly Improves the Distinction Between AML and ALL in Adult Acute Leukemias of Ambiguous Lineage

Aniko Szabo, MD, Mathijs A. Sanders, MSc, Carla Exalto, Jasper E. Koenders, Patricia G. Hoogeveen, Anita M. Schelen, Willemijn van den Ancker, MD MSc, PhD, Arjan A. van de Loosdrecht, MD PhD, Bob Lowenberg, MD PhD, Vincent H.J. van der Velden, PhD, Jan J. Cornelissen, MD PhD, Peter J.M. Valk, PhD, Anita W. Rijneveld, MD PhD

Blood (2014) 124 (21): 1067.

https://doi.org/10.1182/blood.V124.21.1067.1067

Published: 2014

Journal Articles

Alloantibody Formation In Sickle Cell Disease

Joep Sins, MD, MSc, Saurabh Zalpuri, MD, PhD, Marjon Cnossen, MD, PhD, Anita W. Rijneveld, MD, PhD, Jean-Louis Kerkhoffs, MD, PhD, Alfred van Meurs, MD, Yolanda de Rijke, PhD, Marjolein Peters, MD, PhD, Bart J. Biemond, MD, PhD, Anske van der Bom, MD, PhD, Karin Fijnvandraat, MD, PhD

Blood (2013) 122 (21): 2395.

https://doi.org/10.1182/blood.V122.21.2395.2395

Published: 2013

NARROW

Preclinical Development of AT1412, a Patient Derived CD9 Antibody That Does Not Induce Thrombosis for Treatment of B ALL

Real-World Effectiveness and Safety of Blinatumomab in Adults with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukaemia in Europe: 3-Year Results in Philadelphia Chromosome-Negative Patients and a Subset of Patients with Late First Relapse

AT1412, a Patient-Derived Antibody in Development for the Treatment of CD9 Positive Precursor B-Acute Lymphoblastic Leukemia

Extensive RAG-Mediated Rearrangements and Mutations in BCR-ABL1 and BCR - ABL1 -like Adult Acute Lymphoblastic Leukemia

N-Acetylcysteine in Patients with Sickle Cell Disease: A Randomized Controlled Trial

Value-Based Health Care (VBHC) in Sickle Cell Disease: A Dutch Initiative

Extensive Molecular Analysis Strongly Improves the Distinction Between AML and ALL in Adult Acute Leukemias of Ambiguous Lineage

Alloantibody Formation In Sickle Cell Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only